The study, led by senior author Domenico Praticὸ, MD, Professor of Pharmacology, Microbiology & Immunology and in the Center for Translational Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM), and colleagues at LKSOM and the Temple University School of Pharmacy, offers some hope for a new treatment for patients with AD, who currently have no effective therapy options.